Better benefits start here
Prime integrates with health plans for total drug management — no matter where medicine happens or how it’s reimbursed. We’re member-centric, provider-aligned and data-driven. And we’re here to help make better, more affordable care easier for everyone.
Executive perspectives
At Prime, we’re focused on redefining our company and how we deliver integrated drug management to support the needs of clients and the members they serve. Dave Schlett, President, PBM Solutions, shares his thoughts about what we accomplished in 2022, and where we are headed in 2023.
Prime’s owner clients
Blue Cross and Blue Shield of Alabama
Blue Cross and Blue Shield of Kansas
Blue Cross and Blue Shield of Minnesota
Blue Cross and Blue Shield of Nebraska
Blue Cross and Blue Shield of North Carolina
Blue Cross Blue Shield of North Dakota
Blue Cross Blue Shield of Rhode Island
Blue Cross Blue Shield of Wyoming
Capital BlueCross
Florida Blue
Health Care Services Corporation (HCSC)
Blue Cross and Blue Shield of Illinois
Blue Cross and Blue Shield of Texas
Blue Cross and Blue Shield of Oklahoma
Blue Cross and Blue Shield of New Mexico
Blue Cross and Blue Shield of Montana
Regence Health Plans
Regence Blue Shield Idaho
Regence Blue Cross Blue Shield of Oregon
Regence Blue Cross Blue Shield of Utah
Regence Blue Shield Washington
PRIME AND MAGELLAN RX
Joining forces for a brighter future
Prime Therapeutics closes $1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise. The combination creates an opportunity to transform the industry by driving affordability and integrating whole-person care to enhance the patient, provider and customer experience.
Consultant Leadership
Driving greater use of biosimilars to help lower drug costs
As part of our total drug management strategy, we actively promote evidence-based use of biosimilars (and other low-cost drug options) that are endorsed by our Phamracy and Therapeutics Committee.
Our solutions
We take an integrated, channel-optimized, approach to design people-centered products that help manage cost and provide smarter care.
Our approach
We’re unlocking the potential of integrated drug management to help lower costs and deliver better outcomes.
Our story
Built on a unique business model we’ve become a leading integrated drug management company.
Related research
Perspectives
March 30, 2023
Drug oversupply, or stockpiling, due to overlapping drug refills can cause unnecessary drug costs
If you have a chronic condition, your pharmacy may notify you advance of…
Perspectives
March 28, 2023
Biosimilars are at the door, Part 3
News about biosimilars is everywhere. Sometimes you just need the basics. This four-part…
Perspectives
March 27, 2023
Specialty Drug Pipeline Update: March 2023
This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
Each Blue Cross® and/or Blue Shield® plan is an independent licensee of the Blue Cross and Blue Shield Association.